I

Inexia

10 employees

Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Neuroscience

Health Care

Pharmaceutical

Date founded

2019

Funding rounds raised

I

Inexia raised undisclosed on February 4, 2019

Investors: Medicxi

FAQ